HCRT and Parkinson disease: In transgenic PD models (A53T mice), α-Syn accumulations in hypothalamic orexin neurons were observed in the early stage, and orexin neuronal loss occurred in the late stage, which was accompanied by reduction in fat mass and an increase in energy expenditure [27].